Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionUsca Ria Llc
Latest Disclosed Ownership26,292 shares
Latest Disclosed Value $ 6,409,000
Usca Ria Llc reports 0.03% decrease in ownership of AMGN / Amgen Inc.

On July 28, 2021 - Usca Ria Llc filed a 13F-HR form disclosing ownership of 26,292 shares of Amgen Inc. (US:AMGN) valued at $6,408,675 USD as of June 30, 2021. The entity filed a previous 13F-HR on April 27, 2021 disclosing 26,301 shares of Amgen Inc.. This represents a change in shares of -0.03% during the quarter. The current value of the position is $9,191,157 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-07-28 2021-06-30 13F AMGEN COM 031162100 26,292 -9 -0.03 6,409 -2.06 0.3888
2021-04-27 2021-03-31 13F AMGEN COM 031162100 26,301 12,818 95.07 6,544 111.10 0.4302
2021-01-27 2020-12-31 13F AMGEN COM 031162100 13,483 -41 -0.30 3,100 -9.81 0.2176
2020-10-27 2020-09-30 13F AMGEN COM 031162100 13,524 127 0.95 3,437 8.77 0.2694
2020-08-13 2020-06-30 13F AMGEN COM 031162100 13,397 -347 -2.52 3,160 13.42 0.2796
2020-04-22 2020-03-31 13F/A-2 AMGEN COM 031162100 13,744 1,223 9.77 2,786 -7.69 0.3231
2020-04-22 2020-03-31 13F/A-1 AMGEN COM 031162100 46,604 32,860 9,448 0.5910
2020-01-27 2019-12-31 13F AMGEN COM 031162100 12,521 1 0.01 3,018 24.56 0.2699
2019-11-07 2019-09-30 13F/A-1 AMGEN COM 031162100 12,520 -3,752 -23.06 2,423 -19.21 0.2382
2019-10-31 2019-09-30 13F AMGEN COM 031162100 12,520 -3,752 2,423 231,213.1316
2019-08-14 2019-06-30 13F/A-1 AMGEN COM 031162100 16,272 -6,066 -27.16 2,999 -29.34 0.3044
2019-08-02 2019-06-30 13F AMGEN COM 031162100 16,272 16,272 2,999
2019-08-14 2019-03-31 13F/A-1 AMGEN COM 031162100 22,338 877 4.09 4,244 1.58 0.4617
2019-02-12 2018-12-31 13F AMGEN COM 031162100 21,461 4,401 25.80 4,178 18.16 0.5559
2018-11-02 2018-09-30 13F AMGEN COM 031162100 17,060 -3,047 -15.15 3,536 -4.74 0.3601
2018-08-08 2018-06-30 13F AMGEN COM 031162100 20,107 -8,927 -30.75 3,712 -25.01 0.3987
2018-05-09 2018-03-31 13F AMGEN COM 031162100 29,034 -4,046 -12.23 4,950 -13.96 0.5453
2018-02-09 2017-12-31 13F AMGEN COM 031162100 33,080 -3,343 -9.18 5,753 -8.29 0.6350
2017-11-07 2017-09-30 13F AMGEN COM 031162100 36,423 0 0.00 6,273 0.00 0.8116
2017-08-07 2017-06-30 13F AMGEN COM 031162100 36,423 23,837 189.39 6,273 203.78 0.8035
2017-05-01 2017-03-31 13F AMGEN COM 031162100 12,586 -10,428 -45.31 2,065 -38.63 0.3028
2017-02-09 2016-12-31 13F AMGEN COM 031162100 23,014 18,077 366.15 3,365 308.37 0.5179
2016-11-15 2016-09-30 13F AMGEN COM 031162100 4,937 -6,882 -58.23 824 -54.17 0.1365
2016-08-13 2016-06-30 13F AMGEN COM 031162100 11,819 272 2.36 1,798 3.87 0.3021
2016-05-23 2016-03-31 13F/A-1 AMGEN COM 031162100 11,547 7,085 158.79 1,731 139.09 0.3140
2016-05-16 2016-03-31 13F AMGEN COM 031162100 1,731,273 11,547
2016-02-08 2015-12-31 13F AMGEN COM 031162100 4,462 503 12.71 724 32.12 0.1564
2015-11-13 2015-09-30 13F AMGEN COM 031162100 3,959 712 21.93 548 10.04 0.1376
2015-09-17 2015-06-30 13F/A-1 AMGEN COM 031162100 3,247 221 7.30 498 2.89 0.1320
2015-08-12 2015-06-30 13F AMGEN COM 031162100 2,212 273
2015-09-17 2015-03-31 13F/A-1 AMGEN COM 031162100 3,026 212 7.53 484 8.04 0.1297
2015-06-03 2015-03-31 13F AMGEN COM 031162100 2,212 273
2015-02-11 2014-12-31 13F AMGEN COM 031162100 2,814 302 12.02 448 26.91 0.1237
2014-11-14 2014-09-30 13F AMGEN COM 031162100 2,512 100 4.15 353 23.43 0.1076
2014-08-28 2014-06-30 13F AMGEN COM 031162100 2,412 200 9.04 286 4.76 0.0959
2014-05-12 2014-03-31 13F AMGEN COM 031162100 2,212 -5,977 -72.99 273 -70.77 0.0981
2014-02-05 2013-12-31 13F AMGEN COM 031162100 8,189 8,189 934 0.3728
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.